Delivra Health Brands Inc. (TSXV: DHB / OTCQB: DHBUF) achieved record revenue in FY2024, growing 26% year-over-year, largely driven by strong U.S. sales of its Dream Water sleep aid products. The company expanded its product line with Dream Water Sleep Gummies and Dream Water Immunity Shots, contributing to increased distribution across 30,000+ retail locations, including major chains like Walmart, Kroger, and Shoppers Drug Mart, and e-commerce platforms such as Amazon and Shopify. U.S. and Midd...
We're excited to share some news about Delivra Health Brands Inc. (NASDAQ: DHBUF | TSX: DHB.V). Since our last research report in February, DHB has seen a remarkable 29% increase in its stock price, and an impressive 80% rise since our initial report in September 2023. Recent Performance: DHB is up 29% since our previous report in February 2024 and 80% since our initial report in September 2023. Q3-FY2024 revenue increased by 31% YoY, driven by robust sales growth across all brands. Financial P...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.